News

"Great Advances in Oncology” – Episode 1/4. Developed in the 1940s by Professor Pierre Denoix, the TNM classification has gradually become the tool that enables oncologists worldwide to determine the stage of their patients’ cancer within a unified framework. Still in use today, it reached its 9th edition in 2025.

The Cancer Research Institute (CRI) has awarded the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology to Prof. Éric Vivier, holder of the Natural Killer (NK) Cell Chair of the Fondation Gustave Roussy. This distinction, one of the most prestigious in cancer immunology, recognizes his body of work, which has profoundly...

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine. The goal is to develop a new generation of immunotherapies that...

Building on the success of its first two editions, the Gustave Roussy Prize, which recognizes a researcher whose discoveries have had a major impact on the care of patients living with cancer, will be held again in 2027. Applications are open until August 26, 2026, at 4:00 p.m. CEST. Endowed with €200,000, this prestigious prize will be awarded on...

From 17 to 19 June in Paris, the IFODS Congress, a benchmark event for French-speaking oncology, will highlight the latest advances in the global fight against cancer, with insights from leading experts. On Thursday, 18 June, an IFODS/Gustave Roussy presidential session will take stock of key topics in oncology. On the programme: therapeutic...

Last quarter, we also learned that the protein MAdCAM-1 could become a prognostic biomarker in patients with kidney cancer, that a targeted therapy can be effective across several cancer types, that hormone therapy is more effective when combined with other treatments, and that a rare form of lung cancer (RET mutation) is sensitive to a new...

On 28 May, teams from the Department of Anaesthesia, Surgery and Interventional Procedures performed the 60th endoscopic mastectomy at Gustave Roussy. This technique, carried out under continuous visual guidance using a camera, enables the removal of the breast through a very short incision, thereby improving the aesthetic outcomes of breast...

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the leading global events in cancer research, held each year in Chicago, United States. Experts from Gustave Roussy contributed to 107 presentations featured in the 2026 programme, with a particular focus on antibody–drug conjugates (ADCs), a rapidly expanding field across...

Following several pioneering procedures carried out in 2025 on the colon, pharynx and liver, the teams from the Department of Anaesthesia, Surgery and Interventional Medicine (DACI) at Gustave Roussy are continuing to drive innovation in robotic surgery. Using the da Vinci Single Port system, they successfully removed a patient’s diseased...

From April 17 to 22, the American Association for Cancer Research (AACR) is holding its annual congress — one of the three leading global scientific conferences dedicated to oncology — in San Diego, United States. More than 20,000 cancer specialists, both clinicians and researchers, from nearly one hundred countries are expected to present and...